Latest News

Rimoni Industries (TASE:RIMO) just posted its Q3 2025 results, with revenue coming in at 47.5 million ILS and EPS of 1.00 ILS for the quarter. Historically, the company has seen total revenue swing between 40.3 million ILS and 47.8 million ILS over the last six quarters, while EPS has ranged from 1.00 ILS to 1.52 ILS. Operating margins have been steady, reflecting a consistent performance despite the variability in earnings and sales. See our full analysis for Rimoni Industries. Now, let's...

Electra Consumer Products (TASE:ECP) just released its Q3 2025 numbers, reporting total revenue of ₪2.0 billion and basic EPS of ₪1.45 for the quarter. Looking back, quarterly revenue has hovered around the ₪1.8 to 2.0 billion mark over the last year, with EPS ranging from ₪0.09 to ₪2.37, showing some sharp swings each quarter. Investors will be eyeing how profit margins are trending, as these latest results put the company’s recent momentum in the spotlight. See our full analysis for Electra...

Doro (OM:DORO) has posted its third-quarter 2025 results, revealing revenue of 247.7 million SEK and basic EPS of 0.90 SEK, with net income at 21.9 million SEK. Over the past several quarters, the company has seen revenue climb from 206.7 million SEK in Q2 2024 to 247.7 million SEK in the latest quarter. EPS moved from 0.58 SEK to 0.90 SEK. Margins have remained solid, marking a stretch of steady profitability that investors will be parsing for what comes next. See our full analysis for...

One thing we could say about the analysts on Pacific Edge Limited ( NZSE:PEB ) - they aren't optimistic, having just...

Pony AI (PONY) has just reported Q3 2025 results, posting revenue of $25.4 million and a basic EPS of -$0.16. Over recent quarters, the company’s revenue has moved from $14.0 million in Q1 2025, to $21.5 million in Q2, reaching $25.4 million in the latest period, while EPS has remained negative. Despite consistent revenue gains, margins are still challenged as losses persist, keeping profitability in focus for investors. See our full analysis for Pony AI. Now, let’s see how these reported...

Mebuki Financial GroupInc (TSE:7167) has just completed a share buyback, repurchasing over 2.7 million shares between early October and mid-November. With the transaction officially closed, investors may be reassessing the stock's appeal. See our latest analysis for Mebuki Financial GroupInc. Momentum has been strong for Mebuki Financial Group Inc. After concluding its substantial buyback, the stock has surged with a 1-month share price return of almost 9 percent and a year-to-date rally of...

Curious about whether NEC is truly worth its current share price, or if there is still untapped value for investors? Let’s take a closer look before you make any big moves. NEC's stock has experienced an impressive rally recently, climbing 18.0% over the last month and notching a staggering 123.0% gain year-to-date. These are signals of both renewed growth optimism and shifting perceptions of risk. The buzz around NEC has been amplified by industry partnerships and an expanded focus on...

Despite a 36% gain in Pacific Biosciences of California, Inc.'s ( NASDAQ:PACB ) stock price this week, shareholders...

BJ's Restaurants, Inc. ( NASDAQ:BJRI ), is not the largest company out there, but it saw a significant share price rise...

As the U.S. stock market enjoys a promising streak with major indexes on track for their best week since June, investors are eyeing opportunities across various sectors. Penny stocks, though often seen as a niche area of investment, continue to capture attention due to their potential for growth in smaller or newer companies. While the term may seem outdated, these stocks can still offer intriguing prospects when backed by solid financials and strategic positioning in the current market...

As U.S. markets experience a notable upswing, with major indexes on track for their best week since June, investors are keenly observing opportunities to bolster their portfolios amid the positive momentum. In such a dynamic environment, dividend stocks can offer stability and income potential, making them an attractive option for those looking to enhance their investment strategies in a thriving market landscape.

Wondering if Grindr might be a value play or just another hyped-up tech stock? You are not alone. Let's dig into what might really be driving the numbers. The stock has seen some swings lately, dropping 6.3% over the past week and 9.6% in the last month, with year-to-date returns down 27.9%. The 3-year return still sits at an impressive 83.3%. Recently, attention has shifted back to Grindr after management announced strategic platform updates to enhance user safety and engagement. This focus...

Ever wondered if VSE’s impressive run means the stock is now overvalued, or if there is still room for smart investors to get in at a fair price? VSE’s share price has soared, jumping 6.6% over the past week and 94.4% year-to-date, which has certainly caught the market’s attention. Recent news has highlighted VSE’s major contract wins in the aviation services sector and a strategic acquisition in its distribution unit, both of which have sparked renewed optimism. These moves have shifted...

Key Insights The projected fair value for Topicus.com is CA$229 based on 2 Stage Free Cash Flow to Equity Topicus.com's...

Wondering if Rumble’s stock price is a hidden bargain or a red flag? Let’s break it down together with a focus on what really drives value. After a sharp jump of 24.3% over the past week, Rumble shares still show a year-to-date drop of 45.5%, making it one of the more volatile names in the media space. The buzz around Rumble is largely due to its ongoing positioning as a “free speech” video platform, its continued attempts to attract high-profile creators, and recent headlines about...

Wondering if Weibo stock is a hidden bargain or a value trap? Let’s quickly unpack what’s been happening and where it might go from here. Weibo’s share price moved up 0.9% over the last week, but it’s still down 14.4% over the past month, keeping investors alert to both growth potential and risks. Recent headlines have spotlighted renewed interest in Chinese tech stocks amid regulatory shifts and fresh partnership announcements from industry players. This backdrop of evolving sentiment is...

Kura Oncology recently attracted attention after KOMZIFTI, its once-daily oral menin inhibitor, secured full FDA approval for adults with relapsed or refractory acute myeloid leukemia with a susceptible NPM1 mutation. This milestone addresses a treatment gap in AML care. See our latest analysis for Kura Oncology. Kura Oncology’s momentum has picked up meaningfully after KOMZIFTI’s approval, with the share price up over 48% in the past three months and 38% year-to-date. While recent investor...

Even though Intuit Inc.'s ( NASDAQ:INTU ) recent earnings release was robust, the market didn't seem to notice. Our...

Ebara (TSE:6361) just adjusted its financial guidance upward for 2025, increasing forecasts across revenue, operating profit, and net profit. This move suggests growing management confidence and indicates a stronger operating outlook for the year ahead. See our latest analysis for Ebara. Backed by robust fundamentals and the recent completion of a sizeable share buyback, Ebara’s momentum has only accelerated this year. The company boasts a 55.4% year-to-date share price return, while its...

NIO (NYSE:NIO) has just posted its Q3 2025 results, reporting revenue of ¥21.8 billion and a basic EPS loss of -¥1.51. Looking back, the company has seen revenue climb from ¥17.4 billion in Q2 2024 to ¥21.8 billion this quarter, while EPS loss per share has ranged between -¥1.51 in Q3 2025 and -¥3.45 in Q4 2024. While NIO’s top-line numbers look sizable on paper, margins remain pressured and the profitability story is still playing out for investors. See our full analysis for NIO. Now, let's...

In the past week, Pediatrix Medical Group reported third quarter revenues surpassing analyst forecasts by 3.2%, supported by improved collections, higher patient acuity, and a favorable payor mix, despite a year-over-year revenue decline. An additional boost to the outlook came as the White House proposed a two-year extension of key Obamacare subsidies, a policy seen as crucial for healthcare providers targeting the ACA marketplace. We'll explore how strong collection activity and policy...

It's not a stretch to say that IMCD N.V.'s ( AMS:IMCD ) price-to-earnings (or "P/E") ratio of 17.6x right now seems...

International Flavors & Fragrances Inc. ( NYSE:IFF ) has announced that it will pay a dividend of $0.40 per share on...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...